$2.46T
Total marketcap
$84.48B
Total volume
BTC 50.55%     ETH 14.97%
Dominance

Boiron SA BOIRF Stock

36.81 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
642.98M USD
LOW - HIGH [24H]
36.81 - 36.81 USD
VOLUME [24H]
100 USD
{{ volume }}
P/E Ratio
12.52
Earnings per share
2.94 USD

Boiron SA Price Chart

Boiron SA BOIRF Financial and Trading Overview

Boiron SA stock price 36.81 USD
Previous Close 43.37 USD
Open 43.37 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 43.37 - 43.37 USD
52 Week Range 39.95 - 49.53 USD
Volume 109 USD
Avg. Volume 0 USD
Market Cap 939.02M USD
Beta (5Y Monthly) 0.408812
PE Ratio (TTM) 14.127036
EPS (TTM) 2.94 USD
Forward Dividend & Yield 1.02 (2.35%)
Ex-Dividend Date June 1, 2023
1y Target Est N/A

BOIRF Valuation Measures

Enterprise Value N/A
Trailing P/E 14.127036
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.7576685
Price/Book (mrq) 1.4139471
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Boiron SA Stock Price History

Beta (5Y Monthly) 0.408812
52-Week Change 0.86%
S&P500 52-Week Change 20.43%
52 Week High 49.53 USD
52 Week Low 39.95 USD
50-Day Moving Average 43.37 USD
200-Day Moving Average 43.5 USD

BOIRF Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 17.36M
Float N/A
Short Ratio N/A
% Held by Insiders 75.48%
% Held by Institutions 9.13%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.1
Trailing Annual Dividend Yield 2.53%
5 Year Average Dividend Yield N/A
Payout Ratio 0.32869998
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 8.36%
Operating Margin (ttm) 12.80%
Gross Margin 71.07%
EBITDA Margin 16.78%

Management Effectiveness

Return on Assets (ttm) 5.48%
Return on Equity (ttm) 8.13%

Income Statement

Revenue (ttm) 534.24M USD
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 4.59%
Gross Profit (ttm) 379.73M USD
EBITDA 89.69M USD
Net Income Avi to Common (ttm) 44.67M USD
Diluted EPS (ttm) 3.07
Quarterly Earnings Growth (yoy) -15.59%

Balance Sheet

Total Cash (mrq) 250.94M USD
Total Cash Per Share (mrq) N/A
Total Debt (mrq) 22.17M USD
Total Debt/Equity (mrq) 3.98 USD
Current Ratio (mrq) 3.119
Book Value Per Share (mrq) 30.673

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Boiron SA

Country United States
State N/A
City Messimy
Address 2, avenue de l’Ouest Lyonnais
ZIP 69510
Phone 33 4 78 45 61 00
Website https://www.boiron.fr
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 2801

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Q&A For Boiron SA Stock

What is a current BOIRF stock price?

Boiron SA BOIRF stock price today per share is 36.81 USD.

How to purchase Boiron SA stock?

You can buy BOIRF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Boiron SA?

The stock symbol or ticker of Boiron SA is BOIRF.

Which industry does the Boiron SA company belong to?

The Boiron SA industry is Drug Manufacturers-Specialty & Generic.

How many shares does Boiron SA have in circulation?

The max supply of Boiron SA shares is 17.47M.

What is Boiron SA Price to Earnings Ratio (PE Ratio)?

Boiron SA PE Ratio is 12.52040900 now.

What was Boiron SA earnings per share over the trailing 12 months (TTM)?

Boiron SA EPS is 2.94 USD over the trailing 12 months.

Which sector does the Boiron SA company belong to?

The Boiron SA sector is Healthcare.